Coronary Artery Calcification in Type 2 Diabetes Mellitus (USCAC Study)
Recruiting
Observational Study
Type 2 Diabetes
Vascular Calcification
Coronary Artery Calcification
Strains
Epidemiology
microRNA
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,400 (estimated)
- Sponsor
- University of South China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Coronary artery calcification (CAC) is a common complication of type 2 diabetes mellitus(T2DM), which can significantly increase all-cause mortality and the incidence of serious cardiovascular events, and increase the burden of the national economy. The epidemiological characteristics and the clinical progress of CAC are still not clear. Moreover, the pathogenesis of CAC has not yet been fully elu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years old
* Type 2 diabetes is diagnosed according to WHO diagnostic criteria
* Low dose prospectively triggered sequential dual-source CT coronary angiography can be performed at baseline investigation
* Those subjects are able to understand the purpose and procedure…
Contacts